News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
857,879 Results
Type
Article (87226)
Company Profile (722)
Press Release (769906)
Multimedia
Podcasts (163)
Webinars (25)
Section
Business (232969)
Career Advice (4136)
Deals (39781)
Drug Delivery (133)
Drug Development (91201)
Employer Resources (201)
FDA (18245)
Job Trends (17387)
News (397190)
Policy (39894)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (33)
Allergies (117)
Alliances (56979)
ALS (135)
Alzheimer's disease (1640)
Antibody-drug conjugate (ADC) (204)
Approvals (18234)
Artificial intelligence (452)
Autoimmune disease (48)
Automation (23)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (146)
Biotechnology (483)
Bladder cancer (118)
Brain cancer (46)
Breast cancer (435)
Cancer (3516)
Cardiovascular disease (306)
Career advice (3550)
Career pathing (36)
CAR-T (228)
CDC (46)
Cell therapy (625)
Cervical cancer (29)
Clinical research (74895)
Collaboration (1271)
Company closure (4)
Compensation (852)
Complete response letters (50)
COVID-19 (2939)
CRISPR (77)
C-suite (493)
Cystic fibrosis (129)
Data (3710)
Decentralized trials (2)
Denatured (58)
Depression (96)
Diabetes (412)
Diagnostics (7042)
Digital health (30)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (214)
Drug pricing (168)
Drug shortages (36)
Duchenne muscular dystrophy (181)
Earnings (98629)
Editorial (52)
Employer branding (25)
Employer resources (169)
Events (132375)
Executive appointments (952)
FDA (20453)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1126)
Gene editing (163)
Generative AI (44)
Gene therapy (492)
GLP-1 (987)
Government (5345)
Grass and pollen (7)
Guidances (332)
Healthcare (20934)
HIV (48)
Huntington's disease (33)
IgA nephropathy (52)
Immunology and inflammation (218)
Immuno-oncology (17)
Indications (45)
Infectious disease (3156)
Inflammatory bowel disease (178)
Inflation Reduction Act (13)
Influenza (86)
Intellectual property (158)
Interviews (814)
IPO (17921)
IRA (59)
Job creations (5196)
Job search strategy (2863)
Kidney cancer (15)
Labor market (69)
Layoffs (624)
Leadership (30)
Legal (10144)
Liver cancer (89)
Longevity (12)
Lung cancer (510)
Lymphoma (250)
Machine learning (22)
Management (65)
Manufacturing (553)
MASH (117)
Medical device (14824)
Medtech (14841)
Mergers & acquisitions (22672)
Metabolic disorders (1059)
Multiple sclerosis (116)
NASH (23)
Neurodegenerative disease (181)
Neuropsychiatric disorders (49)
Neuroscience (2526)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (54)
Obesity (534)
Opinion (302)
Ovarian cancer (113)
Pain (152)
Pancreatic cancer (145)
Parkinson's disease (213)
Partnered (27)
Patents (380)
Patient recruitment (261)
Peanut (56)
People (66041)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23091)
Phase II (32521)
Phase III (24477)
Pipeline (2429)
Policy (277)
Postmarket research (3554)
Preclinical (10425)
Press Release (72)
Prostate cancer (171)
Psychedelics (49)
Radiopharmaceuticals (281)
Rare diseases (594)
Real estate (7411)
Recruiting (76)
Regulatory (27659)
Reports (64)
Research institute (2674)
Resumes & cover letters (650)
Rett syndrome (11)
RNA editing (15)
RSV (64)
Schizophrenia (117)
Series A (183)
Series B (139)
Service/supplier (30)
Sickle cell disease (75)
Special edition (24)
Spinal muscular atrophy (168)
Sponsored (40)
Startups (4314)
State (2)
Stomach cancer (17)
Supply chain (92)
Tariffs (82)
The Weekly (103)
Vaccines (1006)
Venture capital (63)
Weight loss (366)
Women's health (56)
Worklife (21)
Date
Today (9)
Last 7 days (542)
Last 30 days (2248)
Last 365 days (33883)
2025 (23418)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (78)
Alaska (7)
Arizona (293)
Arkansas (14)
Asia (50781)
Australia (8919)
California (8859)
Canada (2689)
China (831)
Colorado (375)
Connecticut (393)
Delaware (238)
Europe (116613)
Florida (1307)
Georgia (302)
Hawaii (3)
Idaho (67)
Illinois (785)
India (45)
Indiana (427)
Iowa (19)
Japan (266)
Kansas (121)
Kentucky (35)
Louisiana (20)
Maine (75)
Maryland (1209)
Massachusetts (6680)
Michigan (295)
Minnesota (540)
Mississippi (4)
Missouri (113)
Montana (32)
Nebraska (26)
Nevada (101)
New Hampshire (76)
New Jersey (2445)
New Mexico (31)
New York (2415)
North Carolina (1348)
North Dakota (10)
Northern California (3936)
Ohio (279)
Oklahoma (18)
Oregon (49)
Pennsylvania (1849)
Puerto Rico (18)
Rhode Island (44)
South America (1654)
South Carolina (45)
South Dakota (1)
Southern California (3362)
Tennessee (142)
Texas (1384)
United States (32889)
Utah (265)
Virginia (238)
Washington D.C. (82)
Washington State (758)
West Virginia (4)
Wisconsin (91)
There are 857,879 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Monopar to Present New Long-Term Neurological Efficacy and Safety Data for ALXN1840 in Wilson Disease at the 150th American Neurological Association Annual Meeting
September 15, 2025
·
5 min read
Press Releases
Successful Commercial Launch of Ryoncil® Highlighted at Global Healthcare Conferences
September 15, 2025
·
5 min read
Press Releases
Phrontline Biopharma Announces First Patient Dosed in Phase 1 Clinical Trial of TJ101
September 15, 2025
·
2 min read
Press Releases
Lion TCR Achieves Triple FDA Milestones with IND Clearance for Chronic Hepatitis B Following Earlier Fast Track and Orphan Drug Designations
September 15, 2025
·
3 min read
Press Releases
Akeso Announces First Patient Dose in Global Registrational Trial of Cadonilimab (PD-1/CTLA-4) for PD-1 Treatment-Resistant Hepatocellular Carcinoma
September 15, 2025
·
6 min read
Sponsored
Rosnilimab Shows Promise as a Potential Next-Generation RA Therapy
A depleter of pathogenic T cells, rosnilimab’s novel MOA generated a differentiated efficacy, tolerability and safety profile in recent Phase 2b study
September 15, 2025
·
7 min read
Immunology and inflammation
Rush of Targeted Myasthenia Gravis Therapies Hit Once Sparse Market
After decades without much movement, a handful of new treatments for this rare autoimmune disease are now approved, and several companies, including argenx and Regeneron, have recently released promising late-stage trial results.
September 15, 2025
·
6 min read
·
Amanda Heidt
Obesity
EASD 2025: Orforglipron in Focus, the Case for Cardiovascular Benefits, More
While Eli Lilly’s orforglipron is top of mind heading into the European Association for the Study of Diabetes meeting this week, experts told
BioSpace
the conference will also provide important insights into the therapeutic benefits of incretin therapies beyond weight loss.
September 15, 2025
·
6 min read
·
Tristan Manalac
FDA
FDA Action Alert: Merck, Sanofi, Biogen and More
On the FDA’s docket for the back half of September is Merck’s proposed subcutaneous formulation of its blockbuster cancer drug Keytruda.
September 15, 2025
·
6 min read
·
Tristan Manalac
Press Releases
Zymewire Releases Midyear 2025 Biopharma Report, Enriched with Executive Commentary from Q2 Earning Calls
September 12, 2025
·
1 min read
1 of 85,788
Next
